Stock Track | Zoetis Plummets 6.62% Intraday Amid Analyst Target Cuts and Weak Q1 Results

Stock Track05-12

Zoetis Inc. (ZTS) shares plummeted 6.62% during intraday trading on Monday, extending recent losses for the animal health company.

The sharp decline follows a series of analyst price target reductions and disappointing first-quarter financial results. Piper Sandler significantly cut its target price on Zoetis to $90 from $140, while BNP Paribas also lowered its target to $146 from $185. These downgrades come after Zoetis reported Q1 results that missed analyst expectations for both earnings per share and revenue, with management subsequently reducing full-year guidance.

Company executives cited a more challenging operating environment than anticipated, noting heightened price sensitivity among pet owners has led to reduced veterinary visits. This resulted in an 8% decline in U.S. market revenue and an 11% drop in companion animal product sales during the quarter.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment